Gene expression-based outcome prediction in advanced stage classical Hodgkin lymphoma treated with BEACOPP.

MLA

Jachimowicz, Ron D., et al. “Gene Expression-Based Outcome Prediction in Advanced Stage Classical Hodgkin Lymphoma Treated with BEACOPP.” Leukemia, vol. 35, no. 12, Dec. 2021, pp. 3589–93. EBSCOhost, https://doi.org/10.1038/s41375-021-01314-1.

APA

Jachimowicz, R. D., Klapper, W., Glehr, G., Müller, H., Haverkamp, H., Thorns, C., Hansmann, M. L., Möller, P., Stein, H., Rehberg, T., von Tresckow, B., Reinhardt, H. C., Borchmann, P., Chan, F. C., Spang, R., Scott, D. W., Engert, A., Steidl, C., Altenbuchinger, M., & Rosenwald, A. (2021). Gene expression-based outcome prediction in advanced stage classical Hodgkin lymphoma treated with BEACOPP. Leukemia, 35(12), 3589–3593. https://doi.org/10.1038/s41375-021-01314-1

Chicago

Jachimowicz, Ron D, Wolfram Klapper, Gunther Glehr, Horst Müller, Heinz Haverkamp, Christoph Thorns, Martin Leo Hansmann, et al. 2021. “Gene Expression-Based Outcome Prediction in Advanced Stage Classical Hodgkin Lymphoma Treated with BEACOPP.” Leukemia 35 (12): 3589–93. doi:10.1038/s41375-021-01314-1.